BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 18, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2000

View Archived Issues

AxyS enters drug design agreement with Bristol-Myers Squibb

Read More

Generex receives U.S. patent for large-molecule pharmaceutical delivery

Read More

Porphyrins designed at Schering for PDT and MRI

Read More

Case study of (-)-OSU-6162 in Huntington's disease patient

Read More

Cephalon's Provigil beneficial in sleep apnea

Read More

Dainippon and Questcor modify antibacterial research agreement

Read More

Lorus Therapeutics receives US patent for antisense cancer therapies

Read More

U.S. patent issued for B-cell lymphoma therapy

Read More

Progenics reviews progress in development of new AIDS therapies at major conference

Read More

Novogen initiates phase I clinical trial with potential prostate cancer treatment

Read More

NuChem anticancer agent inhibits human melanoma metastasis in mice

Read More

Rhinocort Aqua available across U.S. for allergy relief

Read More

New products enter the pipeline at Bone Care

Read More

BASF initiates phase III clinical trials of D2E7

Read More

Targretin gel formulation granted priority review status

Read More

Inhibitors of cGMP-PDEs under study at Bayer

Read More

Potent cell adhesion inhibitors result from Pharmacia & Upjohn/Tanabe Seiyaku collaboration

Read More

Hair growth promoter described by BMS for use in male pattern baldness

Read More

NIA trial will compare cognitive effects of COX-2 inhibitor versus nonselective NSAID

Read More

HMR contributes novel antihistaminics to Aventis pipeline

Read More

Idun patents new dipeptide mimetics that inhibit ICE/ced-3 cysteine proteases

Read More

Prednisone not effective in AD

Read More

Research on new anti-HIV agents continues at DuPont

Read More

MMP-9: a new target for anti-HIV drugs?

Read More

FluMist provides unexpected protection against flu strain not covered by vaccine in children

Read More

Lack of resistance to investigational NNRTI during early clinical trials

Read More

Triangle presents first clinical data for DAPD at major scientific forum

Read More

LF-16-0687 shows further promise for treatment of traumatic brain injury

Read More

News from 31st SGO: excellent results obtained with OvaRex in selected heavily pretreated patients

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing